In this Issue:
Dulaglutide vs. liraglutide in metformin-treated type 2 diabetes
Fenofibrate and lipids/CV disease in women with type 2 diabetes
Effect of overfeeding on ectopic fat deposition and insulin sensitivity
Hyaluronidase + recombinant human insulin vs. lispro in type 1 diabetes
GLP-1 agonist or bolus insulin with optimised basal insulin in type 2 diabetes
Durability of glycaemic efficacy with dapagliflozin vs. glipizide
Sulfonylurea use and CV disease in type 2 diabetes
Endothelial dysfunction and CV risk in type 2 diabetes
Type 2 diabetes and incidence of CV diseases
Please login below to download this issue (PDF)